Phenytoin Prodrug 3-Phosphoryloxymethyl Phenytoin (ACC-9653): Pharmacokinetics in Patients following Intravenous and Intramuscular Administration
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 78 (11) , 929-932
- https://doi.org/10.1002/jps.2600781110
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Safety, Tolerance and Pharmacokinetics of Intravenous Doses of the Phosphate Ester of 3‐Hydroxymethyl‐5,5‐Diphenylhydantoin: A New Prodrug of PhenytoinThe Journal of Clinical Pharmacology, 1988
- Phenytoin Prodrugs IV: Hydrolysis of Various 3-(Hydroxymethyl)phenytoin EstersJournal of Pharmaceutical Sciences, 1984
- Phenytoin Prodrugs VI: In Vivo Evaluation of a Phosphate Ester Prodrug of Phenytoin after Parenteral Administration to RatsJournal of Pharmaceutical Sciences, 1984
- Phenytoin Prodrugs V: In Vivo Evaluation of Some Water-Soluble Phenytoin Prodrugs in DogsJournal of Pharmaceutical Sciences, 1984
- Phenytoin Prodrugs III: Water-Soluble Prodrugs for Oral and/or Parenteral UseJournal of Pharmaceutical Sciences, 1984
- A program package for simulation and parameter estimation in pharmacokinetic systemsComputer Programs in Biomedicine, 1979
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Sudden death following intravenous sodium diphenylhydantoinAmerican Heart Journal, 1976
- Determination of the pKa' Value for 5,5-DiphenylhydantoinJournal of Pharmaceutical Sciences, 1968
- The cardiocirculatory changes caused by intravenous Dilantin and its solventAmerican Heart Journal, 1967